Is This the Perfect Time to Buy Canopy Growth (TSX:WEED) Stock?

It could be a great time to take a contrarian position in legal marijuana leader Canopy Growth Corp (TSX:WEED)(NYSE:CGC).

| More on:
edit Jars of marijuana

Image source: Getty Images

Investing isn’t just about being right; it’s also about being right at the perfect time. In the early 90s you could have predicted that the rising crop of internet startups were likely to create trillions of dollars in value over their lifetime. However, if you’d invested in these companies right away, you would have probably lost all your money in the dot-com crash of 2001. 

A similar pattern seems to have emerged in Canada’s legal marijuana sector. Savvy investors who bet on legalization early in 2015 and 2016 were rewarded with unbelievable gains when marijuana was officially legalized in 2018. However, the sector failed to live up to expectations in 2019, and valuations came crashing down. 

Industry leader Canopy Growth (TSX:WEED)(NYSE:CGC) probably lost the most. The company’s stock price plunged nearly 70% between April and November 2019. That’s over $12 billion in market capitalization wiped off in fewer than eight months. The company also lost its founder and chief executive officer, while the board initiated a painful restructuring process. 

Canopy wasn’t alone. Many of the company’s top rivals also lost billions in market value and senior staff, as Canadian investors reassessed the true economic impact of legalizing the drug for consumers. Some high-profile names folded, while others trade at a fraction of their former valuation. 

It may be fair to say that the overall sentiment for the legal cannabis sector is as pessimistic as ever, which could mean that it’s the perfect time for investors to take another look under the hood and make some contrarian bets. I believe that industry leader Canopy Growth is probably undervalued for the first time in years. Here’s why. 

Market consolidation

A market correction culls the herd and reduces competitive pressures for the top players. Now that some cannabis producers have gone out of business and plenty of smaller companies face bankruptcy, industry leaders like Canopy Growth can grab more market share and consolidate their position. 

The company already controls roughly one-third of the domestic market, which puts it in a favourable position to dominate foreign markets as well. 

Edibles

In 2019, Canada legalized several new categories of cannabis products beyond the traditional buds and rolls. Now, producers can market edible products such as brownies and beverages like marijuana-infused beer. This move could effectively double or triple the market for cannabis, according to my Fool colleague Ryan Vanzo. 

I believe these new categories should be easier to brand, market and consume, leading to margin expansion for the top players. Canopy already has several well-established brands like Tweed and Tokyo Smoke along with celebrity partnerships with Seth Rogan and Drake that give the company a competitive edge in this arena. 

Resources

Perhaps the best reason to be optimistic about Canopy’s prospects is its unparalleled economic resources. The company has $2.28 billion in cash and cash equivalents and $15 in per share book value, while the market price is $30 per share. It’s also backed by the resources and distribution network of its parent company, Constellation Brands.  

Those resources dramatically increase Canopy’s chances of survival as the market drags itself through this painful consolidation period. 

Bottom line

With its brands, cash, and attractive valuation, it may be the perfect time to add Canopy Growth stock to your long-term growth portfolio. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends Constellation Brands. Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Is Cronos Group (TSX:CRON) a Buy After its 1st-Quarter Performance?

Cronos Group remains a high-risk, high-reward stock, despite its solid first-quarter performance.

Read more »

Cannabis smoke
Cannabis Stocks

Aurora Cannabis Stock Hits 52-Week Low: What Investors Should Know

Aurora Cannabis stock continues to fall, hitting a yearly bottom last week. So what should investors do now?

Read more »

edit Jars of marijuana
Cannabis Stocks

Here’s Why Curaleaf Is a Better Cannabis Stock Compared to Sundial!

Cannabis giant Curaleaf ended 2021 with $1.2 billion in sales, making it one of the largest marijuana companies in the…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

2 Cannabis Stocks Better Than Sundial Growers

Here's why Green Thumb Industries and Cresco Labs are much better long-term bets compared to Sundial Growers.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Hexo Stock Jumps 10% on Definitive Tilray Deal

Hexo (TSX:HEXO)(NASDAQ:HEXO) stock jumped 10% on Monday, as its deal with Tilray (TSX:TLRY)(NASDAQ:TLRY) stock became official.

Read more »

edit Jars of marijuana
Cannabis Stocks

Down 97% From Record Highs, Is Sundial Stock a Buy Right Now?

Despite the 97% decline in Sundial stock from its record high, it remains a risky bet for long-term investors due…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Tilray Stock Rallied After its Q3 Results

Here's why Tilray (TSX:TLRY) stock jumped sharply after announcing its Q3 results.

Read more »

TSX Today
Cannabis Stocks

TSX Today: What to Watch for in Stocks on Tuesday, March 29

TSX investors may want to keep an eye on the latest consumer confidence and job openings data from the U.S.…

Read more »